A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

NCT03678649 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Capecitabine

Sponsor

Zhejiang Cancer Hospital